This study aimed to assess whether the simultaneous activation of PPARγ and inhibition of SGLT2 cotransporters provide additive protection against inflammation and fibrosis which are highly engaged in the progression of DN in experimental type 1 diabetes mellitus. This evidence concerns the gene PPARG and type 1 diabetes mellitus.